Free Trial

Agape ATP (NASDAQ:ATPC) Stock Price Down 3% - Here's What Happened

Agape ATP logo with Medical background

Key Points

  • Agape ATP Corporation shares fell by 3%, trading at $1.28, with a total volume decline of 4% from the average session.
  • Despite the recent drop, analysts at Wall Street Zen upgraded the stock from a "sell" rating to a "hold" rating, indicating potential growth.
  • The company reported a negative net margin of 183.13% and a P/E ratio of -3.12 in its latest earnings results.
  • Five stocks to consider instead of Agape ATP.

Agape ATP Corporation (NASDAQ:ATPC - Get Free Report) was down 3% during trading on Monday . The company traded as low as $1.28 and last traded at $1.28. Approximately 28,738 shares traded hands during mid-day trading, a decline of 4% from the average daily volume of 30,067 shares. The stock had previously closed at $1.32.

Agape ATP Price Performance

The stock's fifty day moving average price is $1.33 and its 200 day moving average price is $1.48. The stock has a market capitalization of $64.51 million, a P/E ratio of -3.15 and a beta of -0.98.

Agape ATP (NASDAQ:ATPC - Get Free Report) last issued its earnings results on Wednesday, August 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. Agape ATP had a negative return on equity of 20.32% and a negative net margin of 183.13%.

Agape ATP Company Profile

(Get Free Report)

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names.

Recommended Stories

Should You Invest $1,000 in Agape ATP Right Now?

Before you consider Agape ATP, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agape ATP wasn't on the list.

While Agape ATP currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.